Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-OutHartmut P.H. Neumann, Alexander Glien, Mercedes Robledo et al.|Cancer Research|2009Cited by 196
Postoperative adjuvant radiochemotherapy with cisplatin versus adjuvant radiochemotherapy with cisplatin and pembrolizumab in locally advanced head and neck squamous cell carcinoma- the study protocol of the Adrisk trialSusanne Wiegand, Andreas Dietz, Gunnar Wichmann et al.|Frontiers in Oncology|2023Cited by 5